secwatch.observer — SEC 8-K summary
======================================

Issuer:     PHIBRO ANIMAL HEALTH CORP (PAHC)
CIK:        0001069899
Form:       8-K
Filed at:   2025-02-05T23:59:59+00:00
Accession:  0001558370-25-000661
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phibro Q2 net sales up 24% to $309M; adjusted EPS $0.54 (+64% YoY); raises FY25 guidance
--------------------------------------------------------------------------------

- Net sales $309.3M (+24% YoY); Animal Health up 33% on Zoetis MFA acquisition added $36.7M.
- Adjusted EBITDA $48.2M (+64% YoY); gross margin up 140 bps to 32.9%.
- Net income $3.2M vs $1.3M prior year; adjusted net income $21.9M (+$8.5M).
- Updated FY2025 guidance: net sales $1.25-1.30B, adjusted EBITDA $172-180M (58% growth midpoint).
- Gross leverage 3.1x; total debt $760.3M; cash $67.1M; free cash flow $15.3M trailing 12M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1069899/000155837025000661/0001558370-25-000661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1069899/000155837025000661/pahc-20250205x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer